The significant anti-tumor effects observed with LNP-IFNβ noted in our study thus serve as an important proof of principle, and provide preliminary data that supports future studies investigating intra-tumoral delivery of IFNβ mRNA using LNPs. The gene discussed is IFNB1; the disease is neoplasm.